UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Global alliance project with Novo Nordisk opens in Korea
The Global Alliance Project with Novo Nordisk conference kicked off Monday ...
by Marian Chu
|
2017-09-18 17:14
라인
Pharmaceutical industry leading new growth in Korea: report
The pharmaceutical industry is leading technological innovation and knowled...
by Nam Doo-hyun
|
2017-09-18 14:50
라인
Opdivo adds one more melanoma indication
Ono Pharma Korea and Bristol-Myers Squibb Korea said Monday their anti PD-1...
by Marian Chu
|
2017-09-18 11:34
라인
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs
South Korean pharmaceutical firms are seeking ways to develop combination d...
by Lee Hye-seon
|
2017-09-18 11:26
라인
HIRA’s drug pricing allegedly favors Green Cross, PMG Korea
The Korea Medical Clinic Association said Friday the Health Insurance Revie...
by Song Soo-youn
|
2017-09-15 17:58
라인
Kolon uses Invossa to attract foreign patients
Kolon Life Science said it made a strategic MOU with Korea Tour Promotion A...
by Lee Hye-seon
|
2017-09-15 17:49
라인
SK Chemicals’ release of test result abroad raises curiosity
SK Chemicals has released the results of its clinical trials of the overact...
by Lee Hye-seon
|
2017-09-15 17:39
라인
Hanmi releases research result of new bio drug in Europe
Hanmi Pharmaceutical released the results of two new bio drugs the company ...
by Lee Hye-seon
|
2017-09-15 14:32
라인
LG Chem promotes antidiabetic Zemiglo in Europe
LG Chemical has launched a symposium to promote its antidiabetics drug Zemi...
by Lee Hye-seon
|
2017-09-15 11:51
라인
In historic move, FDA approves 1st biosimilar to treat cancer
The U.S. Food and Drug Administration Thursday marked a new page in cancer ...
by Marian Chu
|
2017-09-15 11:40
라인
Huons to build new office
Huons Global said Wednesday that it plans to move its headquarters and R&D ...
by Lee Han-soo
|
2017-09-15 10:29
라인
Daewoong wins rights to market hepatitis B treatment
Daewoong Pharmaceuticals대웅제약 (President Lee Jong-wook이종욱) said Thursday tha...
by Constance Williams
|
2017-09-14 19:37
라인
NOAC race: Pradaxa prescription numbers fall behind fast followers
The first product to gain indications for a disease often maintains a domin...
by Marian Chu
|
2017-09-14 19:02
라인
Opdivo vs. Keytruda - which will doctors choose?
Two blockbuster immunotherapies Opdivo and Keytruda gained insurance covera...
by Marian Chu
|
2017-09-14 17:54
라인
Chong Kun Dang enters an osteoporosis therapy market
Chong Kun Dang has entered an osteoporosis therapy market with Prolia (comp...
by Lee Hye-seon
|
2017-09-14 17:53
라인
AstraZeneca regains momentum with positive Imfinzi results
Astra Zeneca Korea said Thursday it had some good news from its phase 3 Pac...
by Marian Chu
|
2017-09-14 13:34
라인
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea
Amgen Korea said it signed a joint promotion agreement with Korean pharmace...
by Marian Chu
|
2017-09-13 18:33
라인
Alvogen Korea to sell Vivus’ obesity drug
Alvogen Korea said Wednesday that it gained exclusive marketing rights to s...
by Marian Chu
|
2017-09-13 18:16
라인
ASEAN officials visit JW’s manufacturing plant
Officials involved in good manufacturing practice (GMP) in 10 member nation...
by Song Soo-youn
|
2017-09-13 18:07
라인
Opdivo’s expanded indications ease cancer patients’ worries
Ono Pharma Korea and Bristol-Myers Squibb said Wednesday that their blockbu...
by Marian Chu
|
2017-09-13 16:57
-
이전
111
112
113
114
115
116
117
118
119
120
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top